The discussions reflect a consensus on the evidence supporting gabapentin's effectiveness for neuropathic pain, with statements like 'the evidence is good' and mentions of corresponding clinical experiences. The tone is informational and collaborative, featuring references to systematic reviews and clinical implications, which emphasizes a moderate but meaningful impact on the understanding and application of gabapentin in medical practice.
AgreementModerate agreement
Most posts acknowledge the reliability of the evidence supporting gabapentin's efficacy, indicating moderate to strong agreement with the review's conclusions.
InterestModerate interest
The discussions show a fair level of curiosity, with some posts referencing specific studies and clinical experiences, but overall seem to be of moderate interest.
EngagementModerate engagement
Participants are actively discussing the topic, sharing personal experiences, referencing additional studies, and engaging with feedback, indicating a moderate level of deep interaction.
ImpactModerate impact
The conversation revolves around clinical relevance and evidence-based conclusions, suggesting the review has a noteworthy influence on perceptions and practices regarding gabapentin use.
Abstract in brief
Gabapentin is widely used to treat chronic nerve-related pain, and this review updates previous research by analyzing studies from January 2014 to January 2017.
The review included 37 randomized controlled trials with a total of 5914 participants, mainly focusing on conditions like postherpetic neuralgia and diabetic nerve pain, using doses of 1200 mg or more daily over 4 to 12 weeks.
The findings assess how effective gabapentin is at relieving pain and examine its side effects, using strict criteria like substantial pain relief (50%) or moderate relief (30%), and methods like pooled data analysis and grading the quality of evidence.]
@Amy_L_Partridge @OregonAdvocate @ibdgirl76 @dtmaust The evidence is good for neuropathic pain. This is usually gabapentin but not with an opioid. https://t.co/a1RfCJVuPE
May 29, 2022 · 1 like · 16,284 followersView post →
IM
IASP_MESISIG
@IASP_MESISIG · X
We have responded to feedback on our review of gabapentin for chronic neuropathic pain in adults; you can view the original comments and our reply here: https://t.co/AgVtnaeQNQ #painevidence
Mar 15, 2019 · 1 like · 1 share · 4,735 followersView post →
IM
IASP_MESISIG
@IASP_MESISIG · X
We have responded to feedback on our review of gabapentin for chronic neuropathic pain in adults; you can view the original comments and our reply here: https://t.co/ir5PNSeIQT #painevidence
Mar 16, 2019 · 1 like · 1 share · 4,735 followersView post →
IM
IASP_MESISIG
@IASP_MESISIG · X
PaPaS Top 10 accessed reviews: Gabapentin for chronic neuropathic pain https://t.co/SAVMVnUcPF
See what else made the top 10 https://t.co/vhEqXLsi0R #painevidence https://t.co/aRmWyplb5G
Nov 13, 2019 · 1 like · 1 share · 4,735 followersView post →
M
MMConneely
@MMConneely · X
@StephenAMcMahon @CMOIreland @ciarakellydoc @PhelanVicky @walls2 Mixed views of the efficacy of gabapentin when compared to side effects for chronic pain/neuropathic pain. Recommend taking a look at BMJ article https://t.co/Dle8Qvd973. Also Cochrane reviews at https://t.co/iMQmIp26CE & https://t.co/cZhuz74302.
Feb 22, 2020 · 1 like · 2,925 followersView post →
NC
Neil O'Connell
@NeilOConnell · X
RT @CochranePaPaS: PaPaS Top 10 accessed reviews: Gabapentin for chronic neuropathic pain https://t.co/SAVMVnUcPF
See what else made the…
Nov 13, 2019 · 1 share · 6,237 followersView post →
This episode explores the use of psilocybin in treating alcohol use disorder, including results from a clinical trial showing reductions in heavy drinking days and discussing related medications and overdose trends.
This episode discusses psilocybin as a treatment for alcohol use disorder, highlighting recent clinical trial findings on reducing heavy drinking days. It also covers issues with prescription access and gabapentin's…
@Amy_L_Partridge @OregonAdvocate @ibdgirl76 @dtmaust The evidence is good for neuropathic pain. This is usually gabapentin but not with an opioid. https://t.co/a1RfCJVuPE
May 29, 2022 · 1 like · 16,284 followersView post →
M
MarkCroucher2
@MarkCroucher2 · X
@DerekGriffin86 @DrDemetry @1gregorross @GNK1 These author's conclusions are generally consistent with my clinical experience. https://t.co/UqIpgSr9jC
@StephenAMcMahon @CMOIreland @ciarakellydoc @PhelanVicky @walls2 Mixed views of the efficacy of gabapentin when compared to side effects for chronic pain/neuropathic pain. Recommend taking a look at BMJ article https://t.co/Dle8Qvd973. Also Cochrane reviews at https://t.co/iMQmIp26CE & https://t.co/cZhuz74302.
Feb 22, 2020 · 1 like · 2,925 followersView post →
DS
Dr. Elden Wayne Whalen III, ShD
@wayne_effect · X
Gabapentin for chronic neuropathic pain in adults https://t.co/nymLAwbPs2
RT @CochranePaPaS: PaPaS Top 10 accessed reviews: Gabapentin for chronic neuropathic pain https://t.co/SAVMVnUcPF
See what else made the…
Nov 13, 2019 · 1 share · 6,237 followersView post →
IM
IASP_MESISIG
@IASP_MESISIG · X
PaPaS Top 10 accessed reviews: Gabapentin for chronic neuropathic pain https://t.co/SAVMVnUcPF
See what else made the top 10 https://t.co/vhEqXLsi0R #painevidence https://t.co/aRmWyplb5G
Nov 13, 2019 · 1 like · 1 share · 4,735 followersView post →
GS
gavin stewart
@metanutter · X
RT @CochranePaPaS: We have responded to feedback on our review of gabapentin for chronic neuropathic pain in adults; you can view the origi…
We have responded to feedback on our review of gabapentin for chronic neuropathic pain in adults; you can view the original comments and our reply here: https://t.co/ir5PNSeIQT #painevidence
Mar 16, 2019 · 1 like · 1 share · 4,735 followersView post →
JP
Javier Portilla
@JavierP11926624 · X
RT @CochranePaPaS: We have responded to feedback on our review of gabapentin for chronic neuropathic pain in adults; you can view the origi…
We have responded to feedback on our review of gabapentin for chronic neuropathic pain in adults; you can view the original comments and our reply here: https://t.co/AgVtnaeQNQ #painevidence
Mar 15, 2019 · 1 like · 1 share · 4,735 followersView post →
N
New Perspective in Diabetic Neuropathy From The Periphery To ...
doi:10.1002/14651858.CD004366.pub4. PMID19588354. [155] Thase, ME. When are psychotherapy and pharmacotherapy combinations the treatment of choice for major ...
Cochrane Database of Systematic Reviews. 2017; doi:10.1002/14651858.CD007938.pub4. Accessed Aug. 19, 2019. Derry S, et al. Pregabalin for neuropathic pain ...
Medicamentos anticonvulsivos: alivio del dolor neural - Mayo Clinic
News
2017; doi:10.1002/14651858.CD007938.pub4. Accessed Aug. 19, 2019. Derry S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database of Systematic ...
Wiffen Et Al-2016-Cochrane Database of Systematic Reviews | PDF ...
News
10.1002/14651858.CD007938.pub3] 1994;56:127-38. [DOI: 10.1016/0304-3959(94) ... [DOI: 10.1002/14651858.CD006601.pub4] Ezzati M, et al. Years lived with ...
No.: CD007938. DOI: 10.1002/14651858.CD007938.pub4; Gabapentin. Drugs.com. Last updated on July 25, 2025. https://www.drugs.com/gabapentin.html. Read next ...
Anti-seizure medications: Relief from nerve pain - Mayo Clinic
News
2017; doi:10.1002/14651858.CD007938.pub4. Accessed Aug. 19, 2019. Derry S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database of Systematic ...